Mizuho Markets Cayman LP Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Mizuho Markets Cayman LP grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7,114.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,123,000 shares of the company’s stock after buying an additional 1,107,434 shares during the quarter. GE HealthCare Technologies accounts for about 4.6% of Mizuho Markets Cayman LP’s portfolio, making the stock its 8th biggest position. Mizuho Markets Cayman LP’s holdings in GE HealthCare Technologies were worth $92,108,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Temasek Holdings Private Ltd purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at about $99,922,000. Nan Fung Trinity HK Ltd. purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at about $23,206,000. Envestnet Asset Management Inc. boosted its holdings in shares of GE HealthCare Technologies by 15.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock valued at $25,452,000 after acquiring an additional 46,231 shares during the last quarter. Sound Shore Management Inc CT boosted its holdings in shares of GE HealthCare Technologies by 14.6% during the 3rd quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock valued at $73,655,000 after acquiring an additional 125,062 shares during the last quarter. Finally, Waverton Investment Management Ltd boosted its holdings in shares of GE HealthCare Technologies by 2.8% during the 3rd quarter. Waverton Investment Management Ltd now owns 1,086,668 shares of the company’s stock valued at $81,582,000 after acquiring an additional 29,897 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on GEHC shares. Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a report on Thursday, April 30th. The Goldman Sachs Group cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $81.00 to $65.00 in a research note on Thursday, April 30th. Jefferies Financial Group lowered their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Argus lowered their price objective on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday. Finally, BNP Paribas Exane lowered their price objective on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $64.23 on Friday. The firm’s 50 day moving average price is $68.45 and its 200-day moving average price is $76.24. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $29.22 billion, a PE ratio of 15.37, a price-to-earnings-growth ratio of 1.45 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter last year, the company earned $1.01 EPS. GE HealthCare Technologies’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insider Activity at GE HealthCare Technologies

In other news, CEO Peter J. Arduini bought 4,169 shares of the firm’s stock in a transaction on Thursday, April 30th. The shares were bought at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the purchase, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Rodney F. Hochman bought 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director owned 1,618 shares in the company, valued at $100,364.54. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 11,847 shares of company stock worth $719,555 in the last 90 days. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.